[Congressional Record Volume 160, Number 97 (Friday, June 20, 2014)]
[Daily Digest]
[Pages D684-D685]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
MISCELLANEOUS MEASURES
Committee on Financial Services: Full Committee concluded markup on 
H.R. 4871, the ``TRIA Reform Act of 2014''; H.R. 4881, to place a 6-
month moratorium on the authority of the Financial Stability Oversight 
Council to make financial stability determinations; and H.R. 4387, the 
``FSOC Transparency and Accountability Act''. The bills were ordered 
reported, as amended.
PERSPECTIVES ON PRIORITIES FOR REVIEW THE QUADRENNIAL HOMELAND SECURITY 
STAKEHOLDER
Committee on Homeland Security: Subcommittee on Oversight and 
Management Efficiency held a hearing entitled ``Stakeholder 
Perspectives on Priorities for the Quadrennial Homeland Security 
Review''. Testimony was heard from public witnesses.
NET NEUTRALITY
Committee on the Judiciary: Subcommittee on Regulatory Reform, 
Commercial and Antitrust Law held a hearing entitled ``Net Neutrality: 
Is Antitrust Law More Effective than Regulation in Protecting Consumers 
and Innovation?''. Testimony was heard from Joshua D. Wright, 
Commissioner, Federal Trade Commission; and public witnesses.

[[Page D685]]


LEGISLATIVE MEASURES
Committee on Natural Resources: Subcommittee on Energy and Mineral 
Resources held a hearing on H.R. 4293, the ``Natural Gas Gathering 
Enhancement Act''; and H.R. 1587, the ``Energy Infrastructure 
Improvement Act''. Testimony was heard from Michael D. Nedd, Assistant 
Director, Minerals and Realty Management, Bureau of Land Management, 
Department of Interior; and public witnesses.
MIXED SIGNALS: THE ADMINISTRATION'S POLICY ON MARIJUANA, PART FOUR--THE 
HEALTH EFFECTS AND SCIENCE
Committee on Oversight and Government Reform: Subcommittee on 
Government Operations held a hearing entitled ``Mixed Signals: The 
Administration's Policy on Marijuana, Part Four--the Health Effects and 
Science''. Testimony was heard from Doug Throckmorton, M.D., Deputy 
Director, Regulatory Programs, Center for Drug Evaluation and Research, 
Food and Drug Administration; Nora Volkow, M.D., Director, National 
Institute of Drug Abuse; and a public witness.
NASA SECURITY ASSESSING THE AGENCY'S EFFORTS TO PROTECT SENSITIVE 
INFORMATION
Committee on Science, Space, and Technology: Subcommittee on Space; and 
Subcommittee on Oversight held a hearing entitled ``NASA Security: 
Assessing the Agency's Efforts to Protect Sensitive Information''. 
Testimony was heard from Richard Keegan, Associate Deputy 
Administrator, National Aeronautics and Space Administration; Belva 
Martin, Director, Acquisition and Sourcing Management, Government 
Accountability Office; Gail A. Robinson, Deputy Inspector General, 
National Aeronautics and Space Administration; and a public witness.
REVIEW OF AWARDING BONUSES TO SENIOR EXECUTIVES AT THE DEPARTMENT OF 
VETERANS AFFAIRS
Committee on Veterans' Affairs: Full Committee held a hearing entitled 
``Review of Awarding Bonuses to Senior Executives at the Department of 
Veterans Affairs''. Testimony was heard from Gina Farrisee, Assistant 
Secretary for Human Resources and Administration, Department of 
Veterans Affairs.
IRS COMMISSIONER JOHN KOSKINEN
Committee on Ways and Means: Full Committee held a hearing on the IRS's 
recent statement about the production of Ms. Lerner's emails. Testimony 
was heard from John Koskinen, Commissioner, Internal Revenue Service.

Joint Meetings

  No joint committee meetings were held.